As the clock struck midnight to herald the start of the 23/24 financial year, Australia’s ability to legally prescribe through qualified medical practitioners MDMA (ecstasy) and psilocybin – the active ingredient in magic mushrooms – became a reality.
A surge in recent research is demonstrating that psychedelics-assisted therapy holds great promise for helping people with a range of existing-treatment resistant conditions.
The products are now legitimised by the Australian federal government as a proven aid in the treatment of post-traumatic stress disorder (PTSD), depression and other mental health issues in what could well be the future of therapeutic aids for these types of ailments – and possibly more.
– Read the entire article at Stockhead.
Original Article
